In addition, patients undergoing hemodialysis (HD patients) have abnormally high plasma Cu/Zn ratios, low activity of superoxide dismutase (SOD), and high levels of oxidative stress; Zn supplementation in HD patients ameliorates Cu/Zn ratios and may reduce oxidative stress [10]. Here, SOD1 is linked to Huntington disease.